findmyKOL

Bart Scott, MD

Enriched profile

Director of Hematology and Hematologic Malignancies, Fred Hutchinson Cancer Research Center; Professor, Transplantation Program, Clinical Research Division · Fred Hutchinson Cancer Research Center

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Seattle, WA · West · United StatesSpecialtyMedical OncologyFocusAcute Myeloid Leukemia Research+4
Active KOLfindmyKOL type: EliteLatest publicationSee ScholarshipOnline presenceNone verifiedPayments2021–2025NIH funding2007–2011Why? →

Bart Scott is Director of Hematology and Hematologic Malignancies, Fred Hutchinson Cancer Research Center; Professor, Transplantation Program, Clinical Research Division at Fred Hutchinson Cancer Research Center. OpenAlex indexes 344 publications with 9,250 citations (h-index 50); ClinicalTrials.gov lists 8 registered studies with this person as an investigator.

Data verified 19 Oct 2026

Overview

Updated 23 Oct 2026

Bart Scott is Director of Hematology and Hematologic Malignancies, Fred Hutchinson Cancer Research Center. The public record shows 344 publications with 9,250 citations (h-index 50), centered on Acute Myeloid Leukemia Research, Hematopoietic Stem Cell Transplantation, Retinoids in leukemia and cellular processes. It also documents an investigator role on 8 registered clinical trials, industry payments reported by 25 companies, 1 NIH-funded awards (2007–2011).

  • Top research focus: Acute Myeloid Leukemia Research
  • 8 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 25 companies

Generated from the cited public record · current as of 23 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
MDS / MPN8 trialsLeukemia (AML/ALL/CML/CLL)6 trialsLeukemia, Myeloid, Acute3 trials

Research focus

OpenAlex concept fingerprint
Acute Myeloid Leukemia ResearchHematopoietic Stem Cell TransplantationRetinoids in leukemia and cellular processesMyeloproliferative Neoplasms: Diagnosis and TreatmentHematological disorders and diagnostics

Drugs & molecules

across trials, industry payments and publications
Onureggeneric · AzacitidineClinical trials—Industry payments68Publications2Rytelogeneric · ImetelstatClinical trials—Industry payments29Publications1Jakafigeneric · RuxolitinibClinical trials—Industry payments160Publications—Ultomirisgeneric · RavulizumabClinical trials—Industry payments84Publications—Reblozylgeneric · LuspaterceptClinical trials—Industry payments78Publications—Inqovigeneric · Cedazuridine / decitabineClinical trials—Industry payments69Publications—Vonjogeneric · PacritinibClinical trials—Industry payments68Publications—Niktimvogeneric · AxatilimabClinical trials—Industry payments34Publications—Empaveligeneric · PegcetacoplanClinical trials—Industry payments31Publications—Ayvakitgeneric · AvapritinibClinical trials—Industry payments16Publications—Inrebicgeneric · FedratinibClinical trials—Industry payments12Publications—Vyxeosgeneric · Cytarabine / daunorubicinClinical trials—Industry payments9Publications—

Works with

trial sponsors and companies reporting payments
Alexion Pharmaceuticals, Inc.Clinical trials—Industry payments219Incyte CorporationClinical trials—Industry payments182E.R. Squibb & Sons, L.L.C.Clinical trials—Industry payments110Celgene CorporationClinical trials—Industry payments84Taiho Oncology, Inc.Clinical trials—Industry payments69Sobi, IncClinical trials—Industry payments39Apellis Pharmaceuticals, Inc.Clinical trials—Industry payments34CTI BioPharma Corp.Clinical trials—Industry payments29Geron CorporationClinical trials—Industry payments29Novartis Pharmaceuticals CorporationClinical trials—Industry payments26GlaxoSmithKline, LLC.Clinical trials—Industry payments20Blueprint Medicines CorporationClinical trials—Industry payments16Daiichi Sankyo Inc.Clinical trials—Industry payments13Jazz Pharmaceuticals Inc.Clinical trials—Industry payments10Fred Hutchinson Cancer CenterClinical trials7Industry payments—MorphoSys, US Inc.Clinical trials—Industry payments6Syndax Pharmaceuticals, Inc.Clinical trials—Industry payments6Takeda Pharmaceuticals U.S.A., Inc.Clinical trials—Industry payments2Abbvie Inc.Clinical trials—Industry payments1BeiGene, Ltd.Clinical trials—Industry payments1Gilead Sciences, Inc.Clinical trials—Industry payments1Jasper Therapeutics, Inc.Clinical trials1Industry payments—Medexus Pharma, Inc.Clinical trials—Industry payments1Rigel Pharmaceuticals, Inc.Clinical trials—Industry payments1TerSera Therapeutics LLCClinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
344publications

Distinct works indexed by OpenAlex, matched via ORCID; 19 in PubMed.

9,250citations

Total citations across indexed works.

50h-index

Hirsch index (OpenAlex). i10-index 136.

Clinical & industry

trials, payments and federal funding
8clinical trials

Investigator role on registered studies.

View trials ↓
25companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
1NIH grants · 2007–2011

Federally funded research awards.

View funding ↓

Public positions

sourced statements on record

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 23 Oct 2026

Listed as an investigator on 8 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 23 Oct 2026

25 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    100%
    Janus-associated kinase (JAK) inhibitors57.7%
    Inrebic100%
    Part D<11 patients
    Antimetabolite42.3%
    Hydroxyurea100%
    Part D<11 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 23 Oct 2026

1 NIH research award on record, funded 2007–2011 per NIH RePORTER. The latest:

Congress activity

Updated 23 Oct 2026

78 congress contributions (2014–2026) across AACR, ASCO, ASH per OpenAlex. The most recent:

Publications

Network

Updated 23 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

H. Joachim Deeg93Roland B. Walter54Elihu H. Estey54Paul C. Hendrie52Pamela Sue Becker52Anna B. Halpern41Guillermo Garcia‐Manero38Mary‐Elizabeth M. Percival38Frederick R. Appelbaum37Wael Saber36Brenda M. Sandmaier34Sarah A. Buckley34Megan K. D. Othus33Barry E. Storer33Mikkael Aaron Sekeres32Rachel B. Salit30Rami S. Komrokji29Michael Robert Savona29Gail J. Roboz27Ryotaro Nakamura27Pavel Kiselev26David P. Steensma26Aaron Thomas Gerds24Betül Oran24Harry Paul Erba23Vikas K Gupta23Jaroslaw Pawel Maciejewski23Daniel Aaron Pollyea21Nico Gagelmann21John O Mascarenhas21Rainer F Storb21Mohamed Lotfy Sorror20David L. Grinblatt20Ted Alan Gooley20Christopher Ramin Cogle20Uday Popat20Richard Thomas Maziarz20Vivian G. Oehler19Ruben A. Mesa19Kelda M. Gardner19

Online presence

Updated 23 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Mentions by others

where others cite or feature them
  • Other

    aamds.org/node/86

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →aamds.org ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 23 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • Board Certification in Medical Oncology

    American Board of Internal Medicine

    2019
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fredhutch.org ↗
  • MD

    University of South Alabama School of Medicine

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aamds.org ↗
  • BS

    Biology and Chemistry, University of Alabama at Birmingham

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fredhutch.org ↗
  • Master of Science in Epidemiology

    University of Washington, Seattle

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aamds.org ↗
  • Medical Oncology Fellowship

    Fred Hutchinson Cancer Research Center

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aamds.org ↗
  • Internal Medicine Residency

    Johns Hopkins Hospital

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aamds.org ↗
  • MD

    University of South Alabama-Mobile School of Medicine

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fredhutch.org ↗
  • BS in Biology and Chemistry

    University of Alabama at Birmingham

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fredhutch.org ↗
  • Residency in Internal Medicine

    Johns Hopkins University School of Medicine

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →fredhutch.org ↗
  • Fellowship in Hematology-Oncology

    University of Washington

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fredhutch.org ↗

Editorial & leadership roles

journal and society appointments

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution
  • Professor

    Division of Hematology and Oncology, University of Washington School of Medicine

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fredhutch.org ↗
  • verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fredhutch.org ↗
  • verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fredhutch.org ↗

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.